← Evidence map

ArticleNature2008

Activating mutations in ALK provide a therapeutic target in neuroblastoma.

Rani E George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

450 papers cite itlatest 60 shown

2008
…
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 18923525